Prognostic value of the autophagy markers LC3 and p62/SQSTM1 in early-stage non-small cell lung cancer.
about
FGF2/FGFR1 regulates autophagy in FGFR1-amplified non-small cell lung cancer cells.Knockout of MARCH2 inhibits the growth of HCT116 colon cancer cells by inducing endoplasmic reticulum stress.Glycine decarboxylase and HIF-1α expression are negative prognostic factors in primary resected early-stage non-small cell lung cancer.p62/SQSTM1-Dr. Jekyll and Mr. Hyde that prevents oxidative stress but promotes liver cancer.Clinical Applications of Autophagy Proteins in Cancer: From Potential Targets to Biomarkers.The immune contexture in cancer prognosis and treatment.Expression analysis of LC3B and p62 indicates intact activated autophagy is associated with an unfavorable prognosis in colon cancer.MicroRNA-320 regulates autophagy in retinoblastoma by targeting hypoxia inducible factor-1α.High Expression of the Mitophagy-Related Protein Pink1 is Associated with a Poor Response to Chemotherapy and a Poor Prognosis for Patients Treated with Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma.Geniposide promotes autophagy to inhibit insulin resistance in HepG2 cells via P62/NF‑κB/GLUT‑4.Polysaccharide from Fuzi protects against Ox‑LDL‑induced calcification of human vascular smooth muscle cells by increasing autophagic activity.The prognostic value of p62 in solid tumor patients: a meta-analysis.Autophagic Regulation of p62 is Critical for Cancer Therapy.Cytoplasmic SQSTM1/ P62 Accumulation Predicates a Poor Prognosis in Patients with Malignant TumorTaurine attenuates arsenic-induced pyroptosis and nonalcoholic steatohepatitis by inhibiting the autophagic-inflammasomal pathwayExpression Analysis of Autophagy Related Markers LC3B, p62 and HMGB1 Indicate an Autophagy-Independent Negative Prognostic Impact of High p62 Expression in Pulmonary Squamous Cell Carcinomas
P2860
Q33742954-506A3C03-15AD-40DB-A800-3A3768E985DAQ38657859-38E7D7F5-A1C5-4B34-82A3-CA81CF9159D8Q38773668-66D91381-3B6B-4D81-9DBB-150C4B11F8F7Q38893853-15D2CE09-F696-4B6F-9CC6-80CE6EB4A679Q39428280-685DD110-E3F1-452F-AC64-6C096DA82C5DQ39456999-592447F3-6EBC-4C43-B27B-BBC8C5B6FA17Q41551291-22608791-ECC0-4946-9646-1FC77370BFA6Q41672427-D18526E9-5F8A-4A7E-B151-5F3DC38C5349Q41911745-2A488FBA-F647-4020-9DCA-51F35BC9B8FBQ47749706-C2F98AB8-4217-441F-BBF3-2D149DD46E20Q49379126-E34116E0-5643-4124-AA0A-C7E203B7DA55Q49436326-129A9974-C7E6-489F-A3FA-E23867DC67D2Q55356891-8BED9C30-E588-4450-B24C-9E3D70A75E73Q58597767-DA7BC26A-5903-4334-AADB-B29C10C12ABEQ58712179-A2B76AB8-F2E7-451D-97E1-9BBF7A6798CEQ58726355-9E9E80F3-312E-459C-8A2F-2F58855684D8
P2860
Prognostic value of the autophagy markers LC3 and p62/SQSTM1 in early-stage non-small cell lung cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 May 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prognostic value of the autoph ...... ge non-small cell lung cancer.
@en
Prognostic value of the autoph ...... ge non-small cell lung cancer.
@nl
type
label
Prognostic value of the autoph ...... ge non-small cell lung cancer.
@en
Prognostic value of the autoph ...... ge non-small cell lung cancer.
@nl
prefLabel
Prognostic value of the autoph ...... ge non-small cell lung cancer.
@en
Prognostic value of the autoph ...... ge non-small cell lung cancer.
@nl
P2093
P2860
P50
P356
P1433
P1476
Prognostic value of the autoph ...... age non-small cell lung cancer
@en
P2093
Anna M Schläfli
Karl-Friedrich Becker
Lukas Bubendorf
Mathias Gugger
Olivia Adams
Ralph A Schmid
Spasenija Savic
P2860
P304
39544-39555
P356
10.18632/ONCOTARGET.9647
P407
P577
2016-06-01T00:00:00Z